MS4A6D动员钙流促进NLRP3炎性小体活化的机制研究
批准号:
81971478
项目类别:
面上项目
资助金额:
57.0 万元
负责人:
陈永文
依托单位:
学科分类:
炎症、感染与免疫
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
陈永文
中文摘要
NLRP3炎性小体异常活化可引发多种炎症疾病,但激活NLRP3的机制尚未明确。前期我们发现巨噬细胞表达MS4A6D可促进[Ca2+]内流并诱导NLRP3炎性小体活化,但其如何调节[Ca2+]内流尚未知。本课题拟:1)使用膜片钳技术探讨MS4A6D有钙库操纵的钙离子(SOC)通道功能并诱导[Ca2+]ex内流;2)使用点突变、截短表达及CO-IP等技术,证明MS4A6D能与Syk激酶结合,激活下游PLCr-IP3-IP3R通路诱导内质网[Ca2+]i释放;3)使用Ms4a6d-/-小鼠,建立[Ca2+]依赖性λ-卡拉胶诱导的足垫肿胀及DSS诱导的结肠炎模型,明确MS4A6D促进[Ca2+]依赖性NLRP3活化及其机制;4)使用油酸/a-亚麻酸配体处理,探讨操纵MS4A6D信号对λ-卡拉胶诱导的足垫肿胀炎症的调节作用。本研究将为NLRP3介导的炎性疾病提供新干预措施。
英文摘要
Hyperactivation of NLRP3- inflammasome contributes to the pathogenesis of multiple diseases whereas the mechanisms underlying control the activation of NLRP3- inflammasome remain poorly understood. Our previous work have demonstrated that macrophages-derived MS4A6D promotes [Ca2+] flux in macrophages, by thus enhances NLRP3 activation and induces the release of IL-1β and IL-18 upon macrophages were treated by NLRP3- inflammasome stimuli. Nevertheless, how MS4A6D induces [Ca2+] influx is unclear. Here we would try to do the following experiments: 1) Investigate whether MS4A6D is function as a voltage-gated Ca2+ channel (VOC) or a receptor-operated calcium channel (ROC) with using the patch clamp technique, by thus it induce excellular [Ca2+] influx; 2) Demonstrate MS4A6D promotes the release of [Ca2+] from (endoplasmic reticulum, ER) via interacting with Syk kinase, thereafter, activating Syk-PLCr-IP3-IP3R cascades to induce [Ca2+] release from ER; 3) Using the Ms4a6d-/- mice to establish NLRP3-dependent mouse models including carrageenan-induced footpad swelling and Dextran Sodium Sulfate (DSS)-induced Colitis, finally demonstrate that MS4A6D can promote [Ca2+]-dependent NLRP3-inflammasome activation in vivo; 4) Illustrate that MS4A6D can control the pathogenesis of carrageenan-induced footpad swelling and DSS-induced Colitis through treating the WT mice with the MS4A6D agonist antibodies or its ligands including oleic acid/alpha-linolenic acid. These findings would highlight MS4A6D as a prospective target for treating NLRP3- associated inflammatory disorders.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
登录
查看更多内容
SARS-CoV-2 Induces Lymphocytopenia by Promoting Inflammation and Decimates Secondary Lymphoid Organs.
SARS-CoV-2 通过促进炎症诱导淋巴细胞减少并摧毁次级淋巴器官
DOI:
10.3389/fimmu.2021.661052
发表时间:
2021
期刊:
Frontiers in immunology
影响因子:
7.3
作者:
[Xiang Q, Feng Z, Diao B, Tu C, Qiao Q, Yang H, Zhang Y, Wang G, Wang H, Wang C, Liu L, Wang C, Liu L, Chen R, Wu Y, Chen Y]
通讯作者:
Chen Y
DOI:
10.13431/j.cnki.immunol.j.20230007
发表时间:
2023
期刊:
免疫学杂志
影响因子:
作者:
[王一行, 朱爱如, 赵金存, 黄小勇, 陈永文]
通讯作者:
陈永文
DOI:
10.3389/fimmu.2023.1130398
发表时间:
2023
期刊:
Frontiers in immunology
影响因子:
7.3
作者:
[]
通讯作者:
Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection.
人类肾脏是新型严重急性呼吸综合征冠状病毒2感染的目标
DOI:
10.1038/s41467-021-22781-1
发表时间:
2021-05-04
期刊:
Nature communications
影响因子:
16.6
作者:
[Diao B, Wang C, Wang R, Feng Z, Zhang J, Yang H, Tan Y, Wang H, Wang C, Liu L, Liu Y, Liu Y, Wang G, Yuan Z, Hou X, Ren L, Wu Y, Chen Y]
通讯作者:
Chen Y
DOI:
--
发表时间:
2020
期刊:
Clinical Infectious Diseases
影响因子:
作者:
[Yueping Liu, Yue Pang, Zhenhong Hu, Ming Wu, Chenhui Wang, Zeqing Feng, Congzheng Mao, Yingjun Tan, Ying Liu, Li Chen, Min Li, Gang Wang, Zilin Yuan, Bo Diao, Yuzhang Wu, Yongwen Chen]
通讯作者:
Yongwen Chen
VSIG4通过衔接蛋白MS4a6D抑制NLRP3炎性小体活化的机制研究
-
批准号:81771691
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2017
-
负责人:陈永文
-
依托单位:
BTLA促进MHV-3病毒诱发暴发性肝衰竭的机制研究
-
批准号:81171585
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:陈永文
-
依托单位:
巨噬细胞特异表达VSIG4抑制T细胞活化在调节动脉粥样硬化斑块形成及稳定中的作用研究
-
批准号:30971099
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2009
-
负责人:陈永文
-
依托单位:
B7-H1拮抗CD4+CD25+Foxp3+调节性T细胞抑制功能的机理研究
-
批准号:30600546
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2006
-
负责人:陈永文
-
依托单位:
国内基金
海外基金